Evidence map›Paper›PMID 36661316›Full record

ArticleJournal of the National Cancer Institute2023

The PhenX Toolkit: standard measurement resources for cancer outcomes and survivorship research.

Larissa Nekhlyudov, Keith Bellizzi, Andrew Galligan, Bellinda King-Kallimanis, Deborah K Mayer, Christine Miaskowski, Talya Salz, Catherine McCarty, Lisa Cox, Christine Hill and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of the National Cancer Institute, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Larissa NekhlyudovDepartment of Medicine, Brigham and Women's Hospital, Boston, MA, USA.ORCID 0000-0001-6747-4209
Keith BellizziHuman Development and Family Sciences, University of Connecticut, Storrs, CT, USA.ORCID 0000-0003-4677-9710
Andrew GalliganDepartment of Pediatrics, University of South Florida (USF Health), Tampa, FL, USA.
Bellinda King-KallimanisLUNGevity Foundation, Bethesda, MD, USA.ORCID 0000-0001-9418-9374
Deborah K MayerLineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Christine MiaskowskiSchool of Nursing, University of California, San Francisco, CA, USA.
Talya SalzDepartment of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Catherine McCartyDepartment of Family Medicine and Biobehavioral Health, University of Minnesota Medical School, Duluth, MN, USA.
Lisa CoxRTI International, Research Triangle Park, NC, USA.
Christine HillRTI International, Research Triangle Park, NC, USA.
Tabitha P HendershotRTI International, Research Triangle Park, NC, USA.
Deborah R MaieseRTI International, Research Triangle Park, NC, USA.
Carol M HamiltonRTI International, Research Triangle Park, NC, USA.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
Genomic Resource Grant for the PhenX Toolkit - expansion and sustainabilityPhenX Supplement for COVID-19 ResearchU41HG007050 · NHGRI · RESEARCH TRIANGLE INSTITUTE · PI HAMILTON, CAROL MARIE · 2013 to 2022
$21.2M
NCI NIH HHS P30 CA008748NIH HHS U41HG007050
6 · The paper itself

Abstract

This brief report introduces the Cancer Outcomes and Survivorship domain in the PhenX Toolkit (consensus measures for Phenotypes and eXposures), which includes 15 validated measurement protocols for cancer survivorship research that were recommended for inclusion in this publicly available resource. Developed with input from the scientific community, the domain provides researchers with well-established measurement protocols for evaluating physical and psychological effects, financial toxicity, and patient experiences with cancer care. The PhenX Toolkit, funded by the National Human Genome Research Institute since 2007, is an online resource that provides high-quality standard measurement protocols for a wide range of research areas (eg, smoking cessation, harm reduction and biomarkers, and social determinants of health). Use of the PhenX Cancer Survivorship Outcomes and Survivorship domain can simplify the selection of measurement protocols, data sharing, and comparisons across studies investigating the cancer survivorship experience.

Indexed as

NeoplasmsSurvivorshipHumansInformation DisseminationPhenotypeResearch Design

Identifiers

PMID36661316
PMCPMC10086624

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.